Insilico Medicine is an AI-driven drug discovery company that uses generative AI to design novel drug molecules, identify disease targets, and predict clinical trial outcomes, with a pipeline spanning oncology, fibrosis, and immunology. It has demonstrated industry-leading speed in generating clinical candidates from concept to IND.
Category
Healthcare
Subcategory
Drug Discovery
Free Tier
Paid Plans
API Cost
Insilico Medicine Trust & Security Report
Certifications, AI-training posture, and security controls, with sourced proof.
Verified against Insilico Medicine's own trust and security pages. See the full report for sourced proof →
Region
Multi-region: Primary processing in Hong Kong. Data stored in Seoul (Korea) for cloud.chemistry42.com SaaS, Ireland for lab.chemistry42.com SaaS. Data transfers to and from Hong Kong documented in privacy policy.
Trains on Data
Yes
Self-hostable
No
